Funding for AUPN's symposium on "Combining Clinical and Research Careers in Neuro

描述(由申请者提供)：本申请旨在为为期一天半的指导研讨会“如何将神经科学的临床和研究事业结合起来(CCRCN)”寻求资助。该项目由大学神经学教授协会(AUPN)(www.aupn.org)、国家神经疾病和中风研究所(NINDS)、美国神经学协会(ANA)和儿童神经病学协会(CNS)共同赞助。AUPN是美国认可的医学院神经科或分部主任的专业组织。它的目标是“通过向神经学实习生提供卓越的教育，并通过扩大有关神经疾病的知识，在神经疾病患者的护理方面做到卓越。”另外两个专业组织，美国神经病学协会(ANA)和儿童神经病学学会(CNS)，与AUPN和NINDS一样，对临床医生-科学家数量的减少表示担忧，并已加入AUPN和NINDS，为CCRCN提供资金支持。CCRCN研讨会于2003年由AUPN和NINDS首次举办，以满足对更多临床医生-科学家的迫切需求，特别是在神经学方面。2005年，JAMA报告称，所有医生中科学家不到2%，尽管研究活动和资金增加，但这一数字继续下降。当这项计划在2003年开始时，趋势显示20年来生物医学研究资金不断增加，但临床医生-科学家队伍惊人地减少了22%；研究表明，超过三分之一的拥有医学博士/博士学位的医学院毕业生没有实现他们成为活跃的临床医生-科学家的最初目标。这次研讨会的具体目的是：1)鼓励接受神经科学研究培训的医学生进行临床培训(特别强调神经学)；2)描述和讨论成功融合临床和研究事业的策略；3)讨论研究和临床事业相结合的满足感和力量；4)描述和讨论获得长期培训和研究支持的来源和策略；以及5)为学生提供机会，让他们与在神经科学中成功结合临床和研究事业的院士见面并建立联系。可能是神经科学研究和临床相结合的研究和临床职业的医学生被邀请参加这次会议。理想的应聘者将完成临床前培训，并至少额外接受一年的神经科学研究培训。进一步考虑的学生谁已经完成了一些必要的临床助理，因为这是许多学生将考虑进一步的临床培训。这次研讨会与任务密切相关。 NINDS，这是为了减轻神经系统疾病的负担。这一值得称赞的目标直接得到了CCRCN的支持，CCRCN努力增加训练有素的临床医生的数量，这些医生是致力于寻找治疗甚至治愈神经系统疾病的方法的科学家。

DESCRIPTION (provided by applicant): This application seeks funding for a one and a half day mentoring symposium entitled "How to Combine Clinical and Research Careers in Neuroscience (CCRCN)". The program is sponsored by the Association of University Professors of Neurology (AUPN) (www.aupn.org), together with the National Institute of Neurological Disorders and Stroke (NINDS), the American Neurological Association (ANA) and the Child Neurology Society (CNS). The AUPN is the professional organization for Chairs of Neurology Departments, or Divisions, in accredited medical schools in the United States. Its goal is "excellence in the care of patients with neurological disease by providing superior education to neurology trainees and by expanding knowledge about neurologic diseases." Two other professional organizations, the American Neurological Association (ANA) and The Child Neurology Society (CNS), share AUPN's and NINDS' concerns regarding the decline in the number of clinician-scientists, and have joined AUPN and NINDS financially supporting the CCRCN. The CCRCN symposium was first offered in 2003 by the AUPN and NINDS to meet the urgent need for more clinician-scientists, specifically in neurology. In 2005, JAMA reported that less than 2% of all physicians are scientists and, despite increases in research activity and funding, this number continues to drop. When this program began in 2003, the trend showed two decades of increasing biomedical research funding but an alarming 22% decrease in the clinician-scientist workforce; studies showed that more than a third of medical school graduates with MD/PhD do not realize their original goal of becoming active clinician-scientists. The specific aims for this symposium are to: 1) encourage medical students with neuroscience research training to pursue clinical training (with special emphasis on neurology); 2) describe and discuss strategies for successfully melding clinical and research careers; 3) discuss the satisfactions and power of a combined research and clinical career; 4) describe and discuss sources of, and strategies for, obtaining long term training and research support; and 5) provide an opportunity for students to meet and network with academicians who have successfully combined clinical and research careers in neuroscience. Medical students who may be candidates for combined research and clinical careers in the neurosciences are invited to apply to attend this meeting. The ideal candidate will have completed preclinical training and at least one additional year of neuroscience research training. Further consideration is given to students who have completed some required clinical clerkships, as this is the time when many students will be thinking about further clinical training. This symposium is highly relevant to the mission of NINDS, which is to reduce the burden of neurological disease. This laudable goal is directly supported by the CCRCN which strives to increase the number of well-trained clinician-scientists working to find treatments, and even cures, for neurological diseases.